Skip to content

Voed je beter met diabetes type 2: The effects of personalized dietary guidance to increase the intake of fibre-rich foods on cardiometabolic risk profile in individuals with type 2 diabetes

Voed je beter met diabetes type 2: The effects of personalized dietary guidance to increase the intake of fibre-rich foods on cardiometabolic risk profile in individuals with type 2 diabetes - Dutch dietary guidelines for type 2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON51759
Enrollment
168
Registered
2022-08-17
Start date
2022-11-10
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-insulin-dependent diabetes type 2 diabetes

Interventions

Personalized dietary guidance to increase the intake of fibre-rich foods on top of usual care. The dietary guidance is implemented by dieticians and is personalized based on adherence to dietary gui

Sponsors

Wageningen Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Diagnosis of type 2 diabetes made by a medical doctor at least 6 months prior to study enrolment • Adult • Willing and able to follow dietary intervention • Willing to participate in both intervention and control group • Living at a reasonable distance from the research center at Wageningen University & Research (WUR) (i.e. maximum of ± 1 hour away)

Exclusion criteria

Exclusion criteria: • Currently treated with insulin therapy • Recently (

Design outcomes

Primary

MeasureTime frame
The main study parameter is the difference in change in cardiometabolic risk profile (HbA1c, LDL-cholesterol, blood pressure and body weight) from baseline until six months between the intervention and the control group.

Secondary

MeasureTime frame
Secondary parameters include a diet quality score for the level of adherence to the Dutch dietary guidelines, blood lipid profile, markers of glucose metabolism, kidney, and liver function, muscle quality and physical performance, patient-oriented outcomes such as medical consumption, productivity, sleep quality, food literacy, quality of life and self-efficacy. These parameters are assessed in blood and 24-hour urine, and by means of measuring body weight, blood pressure, making ultrasound of the leg, fitness tests, a dietary recall, and self-administered questionnaires. To assess whether effects remain after the active intervention period has ended, differences in change between intervention and control group will also be investigated six months after the intervention, i.e. 12 months after the start of the study.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Aug 9, 2026